List of works - Gulietta M Pupo

A genome wide linkage search for breast cancer susceptibility genes

scientific article published on July 2006

A high-throughput panel for identifying clinically relevant mutation profiles in melanoma

scientific article

Acquired BRAF inhibitor resistance: A multicenter meta-analysis of the spectrum and frequencies, clinical behaviour, and phenotypic associations of resistance mechanisms

scientific article

Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource

scientific article

Antiproliferative effects of continued mitogen-activated protein kinase pathway inhibition following acquired resistance to BRAF and/or MEK inhibition in melanoma.

scientific article

BRAF inhibitor resistance mechanisms in metastatic melanoma: spectrum and clinical impact.

scientific article published on 24 January 2014

Clinical significance of intronic variants in BRAF inhibitor resistant melanomas with altered BRAF transcript splicing

scientific article

Comparison of whole-exome sequencing of matched fresh and formalin fixed paraffin embedded melanoma tumours: implications for clinical decision making

scientific article

Differential activity of MEK and ERK inhibitors in BRAF inhibitor resistant melanoma.

scientific article published on 15 January 2014

Identification of TFG (TRK-fused gene) as a putative metastatic melanoma tumor suppressor gene

scientific article published on 17 January 2012

Increased MAPK reactivation in early resistance to dabrafenib/trametinib combination therapy of BRAF-mutant metastatic melanoma.

scientific article published on 2 December 2014

Is MSH2 a breast cancer susceptibility gene?

scientific article published on 6 October 2007

Melanomas of unknown primary have a mutation profile consistent with cutaneous sun-exposed melanoma.

scientific article published on 23 August 2013

PD-L1 Expression and Immune Escape in Melanoma Resistance to MAPK Inhibitors

scientific article

Preexisting MEK1 exon 3 mutations in V600E/KBRAF melanomas do not confer resistance to BRAF inhibitors

scientific article published on April 2012

Tumour procurement, DNA extraction, coverage analysis and optimisation of mutation-detection algorithms for human melanoma genomes.

scientific article published on 29 October 2015

Whole-genome landscapes of major melanoma subtypes.

scientific article published on 3 May 2017

List of works by Gulietta M Pupo

A genome wide linkage search for breast cancer susceptibility genes

A high-throughput panel for identifying clinically relevant mutation profiles in melanoma

Acquired BRAF inhibitor resistance: A multicenter meta-analysis of the spectrum and frequencies, clinical behaviour, and phenotypic associations of resistance mechanisms

Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource

Antiproliferative effects of continued mitogen-activated protein kinase pathway inhibition following acquired resistance to BRAF and/or MEK inhibition in melanoma.

BRAF inhibitor resistance mechanisms in metastatic melanoma: spectrum and clinical impact.

Clinical significance of intronic variants in BRAF inhibitor resistant melanomas with altered BRAF transcript splicing

Comparison of whole-exome sequencing of matched fresh and formalin fixed paraffin embedded melanoma tumours: implications for clinical decision making

Differential activity of MEK and ERK inhibitors in BRAF inhibitor resistant melanoma.

Identification of TFG (TRK-fused gene) as a putative metastatic melanoma tumor suppressor gene

Increased MAPK reactivation in early resistance to dabrafenib/trametinib combination therapy of BRAF-mutant metastatic melanoma.

Is MSH2 a breast cancer susceptibility gene?

Melanomas of unknown primary have a mutation profile consistent with cutaneous sun-exposed melanoma.

PD-L1 Expression and Immune Escape in Melanoma Resistance to MAPK Inhibitors

Preexisting MEK1 exon 3 mutations in V600E/KBRAF melanomas do not confer resistance to BRAF inhibitors

Tumour procurement, DNA extraction, coverage analysis and optimisation of mutation-detection algorithms for human melanoma genomes.

Whole-genome landscapes of major melanoma subtypes.